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ABSTRACT
Helicobacter pylori has been known as a cause of chronic gastritis, a predisposition to gastric and duocenal
ulcers, and a class I gastric carcinogen. Throughout the world, H. pylori infection is very common, reaching
40% -50% of the population in developed nations and 80% – 90% of the population in developing nations.
Several techniques have been used to detect H. pylori infection, such as the urea breath test, rapid urease
test, serological test, as well as biopsies of gastric or duodenal tissues for culture and histopathology. In this
review article, we will discuss a relatively new method to detect H. pylori antigen in stools with enzyme
immunoassay, and comparisons with other standard techniques. However, the H. pylori stool antigen test is
not yet commercially available in Indonesia.
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INTRODUCTION
Helicobacter pylori is a bacteria that infects over 50%
of the human population.1  H. pylori infection
particularly occurs during childhood, and resides in the
gastric mucosa for long periods of time, or even
eternally, if no erradication measures with specific a
ntibiotics are taken. In South and Central America, Asia
and Africa, approximately  80%  of all children are
infected by H. pylori at the age of 10 years. Worldwide,
H. pylori is very common, reaching 40- 50% of all
populations in developed nations and 80-90% of all
population in developing nations. In Indonesia,
seroepidemiologic studiens at several centers found a
prevalence rate of 36-64,3%, with the youngest age of
infection at 5 months.2
Warren and Marshall were the first to report
H. pylori bacteria and its histological correlation with
gastritis. This bacteria is associated with acute and   active
chronic gastritis, peptic ulcer, and atrophic gastritis.1,3
H. pylori is considered as a class I gastric carcinogen,
since its involvement is suspected in gastric
adenocarcinoma and mucosa-associated lymphoid
tissue (MALT) lymphoma.4,5,6,7,8 H. pylori erradication
in patients with low-grade lymphoma produces a
remission rate in approximately 80% of all patients.9
Presently, several invasive as well as non-invasive
methods are available to detect H. pylori infection, such
as the urea breath test, the rapid urease test, serologic
testing, and gastric or duodenal tissue biopsy by
endoscopy for culture and histopathological evaluation.
Nonetheless, for the patient’s comfort, diagnostic
acuracy, and evaluation of erradication treatment,
various new methods have been developed in the hope
to find a better diagnostic test. Recently, the non-
invasive enzyme immunoassay (EIA) technique to
detect H. pylori antigen in the patient’s stool (H. pylori
stool antigen (HpSA) has been developed. This method
has been used in various countries to diagnose H. pylori
infection, and even as a follow-up/evaluation of
erradication treatment.
CHARACTERISTICS OF HELICOBACTER PYLORI
H. pylori is a negative-Gram bacteria, shaped as
spiral, the letter S or curved, is micro-aerophillic, 0.5 x 3
mm in size, and has 4 to 7 coated flagels at one end.
When dormant, the bacteria is shaped like a cocoid, and
thus can survive in difficult environments. Its natural
habitat is the human gaster. However, H. pylori can also
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be found in primates and cats.10
H. pylori can produce a number of important
virulence factors to be able to colonize the gaster and
survive in unfriendly environments. The factors include:1
1. Urease, which plays an important role in neutralizing
gastric acid secretion.
2. Flagel, to assist H. pylori in swimming in the mucous
layer.
3. Superoxide dysmutase.
4. Several molecules involved in the specific adhesion
to gastric superficial epithelial cells.
5. Cytotoxin-associated gene (CagA) and vacuolating
cytotoxin (VacA) proteins, only produced by certain
types of H. pylori.
To detect the presence of a microorganism, it is also
important for us to know the mechanism for its
transmission, to be able to determine the best method of
evaluation for certain specimens.
H. Pylori transmission can occur through the following
three (3) pathways:
1. Fecal-oral; H. pylori has been isolated in feces.11
2. Oral-oral; H. pylori has been isolated from the mouth
cavity.
3. Iatrogenic; transmission from instruments for
endoscopy, biospy forceps, or pH electrode contami-
nated with H. pylori.
TESTS TO DETECT H. PYLORI
The Urea Breath Test
The urea breath test (UBT), which uses the isotop
13C or 4C is an easy to perform non-invasive
examination. Unlike the serological test, a positive result
on the UBT signifies current H. pylori infection with a
high sensitivity and specificity rate.12 The goal of the
UBT is to evaluate H. pylori urease activity. The UBT
is able to prevent errors due to incorrect endoscopic
biopsy sampling in cases of patchy gastritis. The UBT
can be used to evaluate H. pylori 4 weeks after the
administration of antibiotics, when serologic testing still
produces a positive result.2,13  False negatives occur if
H. pylori has been suppressed by treatment with
antibiotics or proton pump inhibitors.12 UBT has
a sensitivity rate of 95-99% and a specificity of 94-99%,
while for the evaluation of post-H. pylori erradication
treatment, it has a sensitivity rate of 94% and a
specificity rate of 95%.9 Cutler et al (1995) in his study
compared the sensitivity and specificity of several
diagnostic procedures for H. pylori and found the
non-invasive UBT procedure as acurate as the
campylobacter like organism test (CLO test) and
Warthin-Starry staining to determine the H. pylori   sta-
tus in patients that have not undergone treatment.14 How-
ever, the cost to perform this test and the complecity of
the instruments cause this test to be rarely used.
Serological Testing
The objective of serological testing is to detect IgG
anti-Hp antibodies. This test is non-invasive and is not
too expensive compared to the UBT. However, since it
requires blood sampling, it sometimes becomes a
problem, particularly in children. After treatment for H.
pylori, the serological titer for anti-Hp antibodies is slowly
reduced within several months to several years, but does
not always become negative. In addition, within 6 weeks
after treatment for the erradication of H. pylori, the level
of H. pylori antibodies only falls to 50-60% from the
level before treatment, thus making it more difficult to
evaluate the success of treatment.15 A positive
serological test result does not always determine cuurent
infection with life bacteria. Serological testing is
recommended for epidemiological surveys.2,13 It has a
sensitivity and specificity rate of only 82% and 81%,
respectively.9 A meta-analysis study on 11 commercial
enzyme-linked immunoadsorbent assay (ELISA) kit and
1 latex agglutination kit found a sensitivity rate of 85%
and a specificity rate of 79%.16
 Polymerase Chain Reaction
Detection of H. pylori using the polymerase chain
reaction (PCR) method was first introduced in early 1990.
Because of its sensitivity, PCR is the method of choice
to evaluate treatment response, if treatment has been
able to reduce the number of bacteria. PCR can be
performed from samples from saliva, dental plaques,
gastric aspiration, and feces. PCR evaluation from
gastric aspiration fluid has a sensitivity and specificity
rate of 96% and 96% respectively compared to culture
and histological evaluation from antrum biopsy
specimens. 17 For H. pylori detection from fecal samples,
the PCR has a specificity and sensitivity rate of 93,7%
and 100%  respectively.3 Up to now, the PCR has not
been frequently used for daily clinical purposes, and is
instead more commonly used for research purposes.
Culture
H. pylori can be cultured from gastric biopsy, but the
process is slow and requires a specific culture media, thus
causing this method to be rarely used.12 The sensitivity
rate can reach over 95%, but other methods to diagnose
H. pylori are relatively easier and produces more rapid
results. The advantage of performing a culture is the
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ability to determine antibiotic resistance. In the case of
patchy H. pylori infection, it is difficult to obtain a
representative sample for this method of  evaluation.14
Histopathology
The gold standard for the diagnosis of H. pylori is to
detect the organism from gastric biospy that has been
processed with histological staining. The sensitivity rate
for biopsy reaches 100% for biopsy of the angulus,
96-97% for antrum biopsy and 91-94% for corpus
biopsy. If biopsy is taken from the antrum and corpus,
the sensitivity rate can reach 100%. Specimen staining
methods can influence the acuracy of H. pylori
detection.14 If examined by an experienced pathologist,
routine staining with hematoxyllin and eosine can
demonstrate the presence of H. pylori. The presence of
polymorphonuclear leukocytes in the inflammed gastric
mucosa supports H. pylori gastritis due to other causes
(such as alcohol and non-steroid anti-inflammatory
agents), and does not produce significant PMN
infiltration.12 Other staining include Giemsa,
Warthin-Starry and Genta.
Rapid Urease Test
The rapid urease test, also known as the CLO test,
was developed by Marshall and specifically designed to
detect H. pylori. It has a sensitivity rate of approximately
90%, but varies from one study to the next, even within
each institution. Its specificity reaches 95-100%.
Gastric biopsy is placed in a media containing urea and
phenophtaline. With the presence of H. pylori urease,
urea is conversed into ammonium hydroxide, which
changes the color of the indicator from yellow to red.
A positive CLO test in patients with peptic ulcer is a
strong proof of H. pylori infection. If the CLO test proves
negative, further histological evaluation is required. As
in the UBT, the CLO test and result in a false negative
in   patients whose infection is suppressed by antibiotics
or proton-pump inhibitors.12 Due to its high cost, the CLO
test has become more difficult to obtain in Indonesia.
Enzyme Immunoassay Test for HpSA
It has been proven that patients infected with
H. pylori can excrete H. pylori bacteria in their feces,
thus allowing the bacteria to be detected in fecal
specimen using PCR or culture. 3,11 However, culture of
H. pylori from the feces is very difficult, since it is few
in number, and PCR is costly. Thus, these two methods
cannot be used as routine diagnostic procedures. Thus,
a new method using the EIA, which is able to detect H.
pylori antigen in human feces was developed (HpSA).
The method of evaluation is roughly as follows. The
fecal sample is mixed with 200ml of the sample solvent.
The fecal sample is then dissolved with peroxidase
conjugated polyclonal antibody and inserted into the
micro-well, to then be incubated for 1 hour in room
temperature. After the discs are washed to eliminate
materials that are not bound, add 2 drops of substrate
liquid and incubate for 10 minutes in room temperature.
The reaction is terminated by dropping 1 drop of
terminating agent. The result is then read using
a spectrophotometer. 18
Makristathis et al. (1998) in his prospective study,
found that EIA has a sensitivity of 88,9% and
a specificity of 94,6% to detect HpSA prior to
eradication treatment. Thus, we could conclude that EIA
is a satisfactory method to detect H. pylori infection in
the feces, since it is just as sensitive as PCR, histology,
and gastric biopsy culture.3
Fanti et al. (1999) in his study to evaluate EIA for
HpSA found that this method has a sensitivity of 98,2%,
with a negative prediction value of 96,4% and
a specificity rate of 93,1% with a positive prediction value
of 96,4%.  Fanti et al concluded that this test has a high
and specific sensitivity for the detection of H. pylori
infection. Nevertheless, the acuracy of EIA in detecting
antigen after erradication treatment requires further
evaluation. The most recent reports demonstrate
conflicting results, even though most studies report a
satisfactory sensitivity and specificity even for HpSA
testing after erradication treatment. Likewise, the
precise point for the monitoring of H. pylori erradication
treatment  needs further evaluation.15
Vaira et al. (1999), in a multi-center prospective study,
found a sensitivity rate of 94,1% and a specificity rate of
91,8% for HpSA testing. The HpSA test and the UBT
conducted 4 weeks after erradication treatment also
found a sensitivity and specificity rates of 90% and 95,3%
respectively for HpSA testing, and 90% and 98,9%
respectively for the UBT. Thus, unlike serologic testing
that requires several months to achieve significant
reduction in antibody titer, the HpSA and UBT with 13C
can be used not long after treatment (4 weeks).4
Forné et al. (2000) compared HpSA testing with   his-
tological methods, , UBT ewith 13C and the rapid   urease
test for the diagnosis of H. pylori infection and to evaluate
the use to determine H. pylori state after        treatment. To
diagnose H. pylori infection, the HpSA test has a sensitiv-
ity and specificity rates of 89,5% and 77,8%    respectively.
The specificity is lower than that of UBT, histological evalu-
ation and rapid urease test. Within 24 hours after treat-
ment, the sensitivity test for HpSA is 0%. Within 6 weeks
after treatment, the     sensitivity falls to 70,4% and 81,6%.
Volume 3, Number 2, August 2002 49
Detection Of Helicobacter Pylori Infection With Stool Antigen: Comparison With Other Techniques
Six months after treatment, the sensitivity and specificity is
further      reduced to50% and 79,3%. Thus, we can con-
clude that the HpSA test is beneficial for the primary diag-
nosis of H. pylori, with a similar sensitivity with other stan-
dard tests, but with a lower specificity. HpSA testing is not
useful for early monitoring to determine the efficacy of
treatment. Within 6 weeks and 6 months after treatment,
for further evaluation of the result of erradication        treat-
ment, HpSA testing is not very accurate compared to the
UBT.18
Rani (2001) in a study on 44 dyspepsia cases found
that the HpSA is quite sensitive (up to 100%), but has a
lower specificity (57,9%). In cases of duodenal ulcer
and gastric carcinoma, H. pylori detection by this means
can reach a rate of 100%.19
 CONCLUSION
• There are several evaluation methods for the
detection of H. pylori infection, which are as
follows: the urea breath test, serological testing, the
rapid urease test, histopathological evaluation,
polymerase chain reaction and enzyme
immunoassay for fecal H.  pylori antigen, with
various advantages and disadvantages.
• The enzyme immunoassay for fecal H. pylori
antigen (HpSA) is expected to be an alternative for
the detection of H. pylori and for further monitoring
of erradication treatment in daily practice.
• Due to inadequate data on the use of HpSA testing,
further studies are required to evaluate the
sensitivity and specificity of HpSA testing, both to
detect H. pylori  as well as to monitoring the
success of erradication treatment.
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